Potent AMA1-specific human monoclonal antibody against P. vivax Pre-erythrocytic and Blood Stages
Preprint
- 8 February 2024
- preprint
- Published by Springer Nature in Research Square
Abstract
New therapeutics are a priority for preventing and eliminating Plasmodium vivax (Pv) malaria because of its easy transmissibility and dormant stages in the liver. Relapses due to the dormant liver stages are the major contributor to reoccurring Pv. Therefore, therapies that reduce the establishment of dormant parasites and blood-stage infection are important for controlling this geographically widespread parasite. Here, we isolated 12 human monoclonal antibodies (humAbs) from the plasma of a Pv-exposed individual that recognized Pv apical membrane antigen 1 (PvAMA1). PvAMA1 is important for both sporozoite invasion of hepatocytes and merozoite invasion of reticulocytes. We identified one humAb, 826827, that blocked invasion of human erythrocytes using a transgenic P. falciparum line expressing PvAMA1 (IC50 = 3 µg/mL) and all Pv clinical isolates in vitro. This humAb also inhibited sporozoite invasion of a human hepatocyte cell line and primary human hepatocytes (IC50 of 0.3 – 3.7 µg/mL). The crystal structure of recombinant PvAMA1 with the antigen-binding fragment of 826827 at 2.4 Å resolution shows that the humAb partially occupies the highly conserved hydrophobic groove in PvAMA1 that binds its known receptor, RON2. HumAb 826827 binds to PvAMA1 with higher affinity than RON2, accounting for its potency. To our knowledge, this is the first reported humAb specific to PvAMA1, and the PvAMA1 residues it binds to are highly conserved across different isolates, explaining its strain-transcendent properties.Keywords
All Related Versions
- Version 1, 2024-02-08, Research Square
- Published version: Nature Communications, 15 (1), 1.
This publication has 50 references indexed in Scilit:
- Defining species-specific and conserved interactions of apical membrane protein 1 during erythrocyte invasion in malaria to inform multi-species vaccinesCellular and Molecular Life Sciences, 2023
- Front Cover: A Chimeric Peptide Inhibits Red Blood Cell Invasion by Plasmodium falciparum with Hundredfold Increased Efficacy (ChemBioChem 7/2023)**ChemBioChem, 2023
- In vitro models for human malaria: targeting the liver stageTrends in Parasitology, 2022
- A single-cell liver atlas of Plasmodium vivax infectionCell Host & Microbe, 2022
- Partial protection against P. vivax infection diminishes hypnozoite burden and blood-stage relapsesCell Host & Microbe, 2021
- Blood-Stage Malaria Parasite Antigens: Structure, Function, and Vaccine PotentialJournal of Molecular Biology, 2019
- Identification of the Binding Site of Apical Membrane Antigen 1 (AMA1) Inhibitors Using a Paramagnetic ProbeChemMedChem, 2019
- The Molecular Basis of Erythrocyte Invasion by Malaria ParasitesCell Host & Microbe, 2017
- The apicomplexan glideosome and adhesins – Structures and functionJournal of Structural Biology, 2015
- Focus on the ringleader: the role of AMA1 in apicomplexan invasion and replicationTrends in Parasitology, 2011